AQST
NASDAQ · Pharmaceuticals
Aquestive Therapeutics Inc
$3.94
+0.02 (+0.51%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+557.4% upside
Low Target
$17.61
Average Target
$25.90
High Target
$34.98
Current Price
$3.94
Current
$3.94
$3.94
Target
$25.90
$25.90
$17.61
$25.90 avg
$34.98
Scenario Analysis
Bear Case
$17.61
347.0%
Low target
Base Case
$25.90
+557.4%
Avg target
Bull Case
$34.98
+787.8%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$7.55
-47.8% from high
52-Week Low
$2.93
+34.5% from low
Target vs 52W High
$25.90
+243.0% vs high
Next Earnings Report
Aug 11, 2026 · After Market Close
1d
tomorrow
EPS Est: $-0.11
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |